Review




Structured Review

Proteintech cd81
Cd81, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 514 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd81/CD81+Antibody/pmc13038339-74-45-50
Average 96 stars, based on 514 article reviews
cd81 - by Bioz Stars, 2026-09
96/100 stars

Images

Related Articles

Incubation:

Article Title: Ferroptosis-dependent small extracellular vesicles ULK1 enhances mitophagy and suppresses breast cancer migration.
Article Snippet: .. Membranes were blocked in 5% non-fat milk prepared in TBST and then incubated overnight at 4 °C with the following primary antibodies: anti-CD63 (abcam, ab216130, 1:1000 dilution), anti-ULK1 (Proteintech, 20986-1-AP, 1:20000 dilution), anti-CD81 (Proteintech, 27855-1-AP, 1:5000 dilution), anti-CD9 (Proteintech, 20597- 1-AP, 1:5000 dilution), anti-calnexin (Proteintech, 10427-2-AP, 1:10000 dilution), anti-LC3 (Proteintech, 14600-1-AP 1:4000 dilution), anti-TOM20 (Proteintech, 11802-1-AP, 1:20000 dilution), anti-CD86 (Santa cruz, sc-19617, 1:200 dilution), anti-206 (Proteintech, 18704-1-AP, 1:2000 dilution), and anti-GAPDH (Proteintech, 60004-1-Ig, 1:2000 dilution) as a loading control. .. After washing, membranes were incubated with appropriate HRP-conjugated secondary antibodies Goat Anti-Rabbit IgG H&L (Beyotime, A0208,1:1000 dilution) or Goat Anti-Mouse IgG H&L AR TIC LE IN PR ES S (Beyotime, A0216, 1:1000 dilution) for 1 hour at room temperature.

Article Title: Ferroptosis-dependent small extracellular vesicles ULK1 enhances mitophagy and suppresses breast cancer migration
Article Snippet: .. Membranes were blocked in 5% non-fat milk prepared in TBST and then incubated overnight at 4 °C with the following primary antibodies: anti-CD63 (abcam, ab216130, 1:1000 dilution), anti-ULK1 (Proteintech, 20986-1-AP, 1:20000 dilution), anti-CD81 (Proteintech, 27855-1-AP, 1:5000 dilution), anti-CD9 (Proteintech, 20597-1-AP, 1:5000 dilution), anti-calnexin (Proteintech, 10427-2-AP, 1:10000 dilution), anti-LC3 (Proteintech, 14600-1-AP 1:4000 dilution), anti-TOM20 (Proteintech, 11802-1-AP, 1:20000 dilution), anti-CD86 (Santa cruz, sc-19617, 1:200 dilution), anti-206 (Proteintech, 18704-1-AP, 1:2000 dilution), and anti-GAPDH (Proteintech, 60004-1-Ig, 1:2000 dilution) as a loading control. .. After washing, membranes were incubated with appropriate HRP-conjugated secondary antibodies Goat Anti-Rabbit IgG H&L (Beyotime, A0208,1:1000 dilution) or Goat Anti-Mouse IgG H&L (Beyotime, A0216, 1:1000 dilution) for 1 h at room temperature.

Control:

Article Title: Ferroptosis-dependent small extracellular vesicles ULK1 enhances mitophagy and suppresses breast cancer migration.
Article Snippet: .. Membranes were blocked in 5% non-fat milk prepared in TBST and then incubated overnight at 4 °C with the following primary antibodies: anti-CD63 (abcam, ab216130, 1:1000 dilution), anti-ULK1 (Proteintech, 20986-1-AP, 1:20000 dilution), anti-CD81 (Proteintech, 27855-1-AP, 1:5000 dilution), anti-CD9 (Proteintech, 20597- 1-AP, 1:5000 dilution), anti-calnexin (Proteintech, 10427-2-AP, 1:10000 dilution), anti-LC3 (Proteintech, 14600-1-AP 1:4000 dilution), anti-TOM20 (Proteintech, 11802-1-AP, 1:20000 dilution), anti-CD86 (Santa cruz, sc-19617, 1:200 dilution), anti-206 (Proteintech, 18704-1-AP, 1:2000 dilution), and anti-GAPDH (Proteintech, 60004-1-Ig, 1:2000 dilution) as a loading control. .. After washing, membranes were incubated with appropriate HRP-conjugated secondary antibodies Goat Anti-Rabbit IgG H&L (Beyotime, A0208,1:1000 dilution) or Goat Anti-Mouse IgG H&L AR TIC LE IN PR ES S (Beyotime, A0216, 1:1000 dilution) for 1 hour at room temperature.

Article Title: Ferroptosis-dependent small extracellular vesicles ULK1 enhances mitophagy and suppresses breast cancer migration
Article Snippet: .. Membranes were blocked in 5% non-fat milk prepared in TBST and then incubated overnight at 4 °C with the following primary antibodies: anti-CD63 (abcam, ab216130, 1:1000 dilution), anti-ULK1 (Proteintech, 20986-1-AP, 1:20000 dilution), anti-CD81 (Proteintech, 27855-1-AP, 1:5000 dilution), anti-CD9 (Proteintech, 20597-1-AP, 1:5000 dilution), anti-calnexin (Proteintech, 10427-2-AP, 1:10000 dilution), anti-LC3 (Proteintech, 14600-1-AP 1:4000 dilution), anti-TOM20 (Proteintech, 11802-1-AP, 1:20000 dilution), anti-CD86 (Santa cruz, sc-19617, 1:200 dilution), anti-206 (Proteintech, 18704-1-AP, 1:2000 dilution), and anti-GAPDH (Proteintech, 60004-1-Ig, 1:2000 dilution) as a loading control. .. After washing, membranes were incubated with appropriate HRP-conjugated secondary antibodies Goat Anti-Rabbit IgG H&L (Beyotime, A0208,1:1000 dilution) or Goat Anti-Mouse IgG H&L (Beyotime, A0216, 1:1000 dilution) for 1 h at room temperature.

Blocking Assay:

Article Title: Downregulated lysyl oxidase in plasma extracellular vesicles: a biomarker linked to brain metastasis risk in lung adenocarcinoma.
Article Snippet: .. After blocking with 5% skim milk, the membrane was probed overnight at 4 °C with the following primary antibodies: anti-CD81 (66866-1-Ig, Proteintech), anti-CD9 (25597-1-AP, Proteintech), anti-TSG101 (ab125011, Abcam), anti-HSP70 (10995-1-AP, Proteintech) and anti-Calnexin (ab22595, Abcam). .. Subsequently, the membrane was washed and incubated with HRP-conjugated secondary antibodies (SA00001-1 and SA00001-2, Proteintech) for 1 h at room temperature.

Membrane:

Article Title: Downregulated lysyl oxidase in plasma extracellular vesicles: a biomarker linked to brain metastasis risk in lung adenocarcinoma.
Article Snippet: .. After blocking with 5% skim milk, the membrane was probed overnight at 4 °C with the following primary antibodies: anti-CD81 (66866-1-Ig, Proteintech), anti-CD9 (25597-1-AP, Proteintech), anti-TSG101 (ab125011, Abcam), anti-HSP70 (10995-1-AP, Proteintech) and anti-Calnexin (ab22595, Abcam). .. Subsequently, the membrane was washed and incubated with HRP-conjugated secondary antibodies (SA00001-1 and SA00001-2, Proteintech) for 1 h at room temperature.



Similar Products

95
Miltenyi Biotec cd81 apc
Cd81 Apc, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd81/CD81+Antibody%2C+anti-human%2C+REAfinity/pm42363190-83-56-58
Average 95 stars, based on 1 article reviews
cd81 apc - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

86
Unchained Labs anti cd81
Anti Cd81, supplied by Unchained Labs, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd81/anti+cd81/pmc13196426-3-5-10
Average 86 stars, based on 1 article reviews
anti cd81 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

95
Miltenyi Biotec anti cd81 pevio770
Anti Cd81 Pevio770, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd81/CD81+Antibody%2C+anti-human%2C+REAfinity/pm42349165-112-37-40
Average 95 stars, based on 1 article reviews
anti cd81 pevio770 - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

86
Abmart Inc cd81
Cd81, supplied by Abmart Inc, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd81/anti+cd9/pm42286608-50-77-79
Average 86 stars, based on 1 article reviews
cd81 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

95
Miltenyi Biotec cd81 pe
Cd81 Pe, supplied by Miltenyi Biotec, used in various techniques. Bioz Stars score: 95/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd81/CD81+Antibody%2C+anti-human%2C+REAfinity/pm42242979-264-43-46
Average 95 stars, based on 1 article reviews
cd81 pe - by Bioz Stars, 2026-09
95/100 stars
  Buy from Supplier

86
Oxford Nanoimaging Ltd anti cd81 alexaflour647
Anti Cd81 Alexaflour647, supplied by Oxford Nanoimaging Ltd, used in various techniques. Bioz Stars score: 86/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd81/alexaflour647+anti+cd81/bio_rxiv__64898__2026__05__05__722048-141-23-24
Average 86 stars, based on 1 article reviews
anti cd81 alexaflour647 - by Bioz Stars, 2026-09
86/100 stars
  Buy from Supplier

96
Proteintech cd81
Cd81, supplied by Proteintech, used in various techniques. Bioz Stars score: 96/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd81/CD81+Antibody/pmc13038339-74-45-50
Average 96 stars, based on 1 article reviews
cd81 - by Bioz Stars, 2026-09
96/100 stars
  Buy from Supplier

91
Boster Bio anti cd81
NsPEFs engineering boosts the production of ADSCs-EVs with superior yield and stability A. Schematic illustration of the high-efficiency extraction of extracellular vesicles (EVs) from adipose-derived stem cells (ADSCs) using nanosecond pulsed electric fields (NsPEFs). B. Representative transmission electron microscopy (TEM) images of isolated Ctrl-ADSCs-EVs and NsPEFs-ADSCs-EVs, showing characteristic cup-shaped morphology and bilayer membrane (scale bars: 150 nm and 75 nm). C. Nanoparticle tracking analysis (NTA) showing the particle size distribution of EVs (n = 3). D. Western blot (WB) analysis confirming the positive expression of EV-specific markers <t>(CD81,</t> CD63, TSG101) and the absence of the negative markers (Calnexin, Histone H3, LaminA/C). Quantification is shown on the right (n = 3). E. The particle concentration of EVs. F. NsPEFs stimulation significantly enhanced both yield and protein output compared to Ctrl-ADSCs-EVs. G. Zeta potential measurement indicating colloidal stability (n = 3). H. Purity assessment expressed as the particle-to-protein ratio ( × 10 9 particles/μg). I. Viability of cells post-NsPEFs-ADSCs-EVs treatment assessed by trypan blue exclusion assay (scale bar: 1.7 mm). Data are presented as mean ± SEM from at least three independent experiments. Statistical significance was determined by unpaired two-tailed Student's t-test or one-way ANOVA with Tukey's post-hoc test. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, and ∗∗∗∗P < 0.0001; ns: not significant.
Anti Cd81, supplied by Boster Bio, used in various techniques. Bioz Stars score: 91/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd81/Anti-CD81+Antibody/pmc12856188-111-66-67
Average 91 stars, based on 1 article reviews
anti cd81 - by Bioz Stars, 2026-09
91/100 stars
  Buy from Supplier

93
Bio-Rad hamster
NsPEFs engineering boosts the production of ADSCs-EVs with superior yield and stability A. Schematic illustration of the high-efficiency extraction of extracellular vesicles (EVs) from adipose-derived stem cells (ADSCs) using nanosecond pulsed electric fields (NsPEFs). B. Representative transmission electron microscopy (TEM) images of isolated Ctrl-ADSCs-EVs and NsPEFs-ADSCs-EVs, showing characteristic cup-shaped morphology and bilayer membrane (scale bars: 150 nm and 75 nm). C. Nanoparticle tracking analysis (NTA) showing the particle size distribution of EVs (n = 3). D. Western blot (WB) analysis confirming the positive expression of EV-specific markers <t>(CD81,</t> CD63, TSG101) and the absence of the negative markers (Calnexin, Histone H3, LaminA/C). Quantification is shown on the right (n = 3). E. The particle concentration of EVs. F. NsPEFs stimulation significantly enhanced both yield and protein output compared to Ctrl-ADSCs-EVs. G. Zeta potential measurement indicating colloidal stability (n = 3). H. Purity assessment expressed as the particle-to-protein ratio ( × 10 9 particles/μg). I. Viability of cells post-NsPEFs-ADSCs-EVs treatment assessed by trypan blue exclusion assay (scale bar: 1.7 mm). Data are presented as mean ± SEM from at least three independent experiments. Statistical significance was determined by unpaired two-tailed Student's t-test or one-way ANOVA with Tukey's post-hoc test. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, and ∗∗∗∗P < 0.0001; ns: not significant.
Hamster, supplied by Bio-Rad, used in various techniques. Bioz Stars score: 93/100, based on 1 PubMed citations. ZERO BIAS - scores, article reviews, protocol conditions and more
https://www.bioz.com/product/anti+cd81/Hamster+anti+Mouse+CD81/pmc12694724-2-2-4
Average 93 stars, based on 1 article reviews
hamster - by Bioz Stars, 2026-09
93/100 stars
  Buy from Supplier

Image Search Results


NsPEFs engineering boosts the production of ADSCs-EVs with superior yield and stability A. Schematic illustration of the high-efficiency extraction of extracellular vesicles (EVs) from adipose-derived stem cells (ADSCs) using nanosecond pulsed electric fields (NsPEFs). B. Representative transmission electron microscopy (TEM) images of isolated Ctrl-ADSCs-EVs and NsPEFs-ADSCs-EVs, showing characteristic cup-shaped morphology and bilayer membrane (scale bars: 150 nm and 75 nm). C. Nanoparticle tracking analysis (NTA) showing the particle size distribution of EVs (n = 3). D. Western blot (WB) analysis confirming the positive expression of EV-specific markers (CD81, CD63, TSG101) and the absence of the negative markers (Calnexin, Histone H3, LaminA/C). Quantification is shown on the right (n = 3). E. The particle concentration of EVs. F. NsPEFs stimulation significantly enhanced both yield and protein output compared to Ctrl-ADSCs-EVs. G. Zeta potential measurement indicating colloidal stability (n = 3). H. Purity assessment expressed as the particle-to-protein ratio ( × 10 9 particles/μg). I. Viability of cells post-NsPEFs-ADSCs-EVs treatment assessed by trypan blue exclusion assay (scale bar: 1.7 mm). Data are presented as mean ± SEM from at least three independent experiments. Statistical significance was determined by unpaired two-tailed Student's t-test or one-way ANOVA with Tukey's post-hoc test. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, and ∗∗∗∗P < 0.0001; ns: not significant.

Journal: Bioactive Materials

Article Title: NsPEFs-enriched ADSCs-EVs alleviate osteoarthritis via RSPO3-mediated dual pro-chondrogenic and pro-M2 macrophage properties

doi: 10.1016/j.bioactmat.2026.01.006

Figure Lengend Snippet: NsPEFs engineering boosts the production of ADSCs-EVs with superior yield and stability A. Schematic illustration of the high-efficiency extraction of extracellular vesicles (EVs) from adipose-derived stem cells (ADSCs) using nanosecond pulsed electric fields (NsPEFs). B. Representative transmission electron microscopy (TEM) images of isolated Ctrl-ADSCs-EVs and NsPEFs-ADSCs-EVs, showing characteristic cup-shaped morphology and bilayer membrane (scale bars: 150 nm and 75 nm). C. Nanoparticle tracking analysis (NTA) showing the particle size distribution of EVs (n = 3). D. Western blot (WB) analysis confirming the positive expression of EV-specific markers (CD81, CD63, TSG101) and the absence of the negative markers (Calnexin, Histone H3, LaminA/C). Quantification is shown on the right (n = 3). E. The particle concentration of EVs. F. NsPEFs stimulation significantly enhanced both yield and protein output compared to Ctrl-ADSCs-EVs. G. Zeta potential measurement indicating colloidal stability (n = 3). H. Purity assessment expressed as the particle-to-protein ratio ( × 10 9 particles/μg). I. Viability of cells post-NsPEFs-ADSCs-EVs treatment assessed by trypan blue exclusion assay (scale bar: 1.7 mm). Data are presented as mean ± SEM from at least three independent experiments. Statistical significance was determined by unpaired two-tailed Student's t-test or one-way ANOVA with Tukey's post-hoc test. ∗P < 0.05, ∗∗P < 0.01, ∗∗∗P < 0.001, and ∗∗∗∗P < 0.0001; ns: not significant.

Article Snippet: The antibodies used and the dilution ratios were as follows:Anti-INOS (1:800, Cohesion), Anti-Arginase 1 (1:800, BOSTER), Anti-LRP6 (1:800, BOSTER), Anti-Beta-catenin (1:800, BOSTER), Anti-CD163 (1:800, Abclonal), Anti-CD86 (1:800, BOSTER), Anti-LGR4 (1:800, Abclonal), Anti-IL-1β (1:800, BOSTER), Anti-IL-10 (1:1000, Bioss), Anti-MMP13 (1:800, BOSTER), Anti-COL2A1 (1:800, BOSTER), Anti-Histone H3 (1:1000, Nature Biosciences), Anti-Lamin A/C (1:1000, Nature Biosciences), Anti-Akt (1:1000, Nature Biosciences), Anti-pAkt (1:1000, Nature Biosciences), Anti-RSPO3 (1:1000, Abcam), Anti-CD63(1:800, BOSTER), Anti-CD81(1:800, BOSTER), Anti-TSG101(1:800, BOSTER), Anti-Calnexin(1:800, BOSTER).

Techniques: Extraction, Derivative Assay, Transmission Assay, Electron Microscopy, Isolation, Membrane, Western Blot, Expressing, Concentration Assay, Zeta Potential Analyzer, Trypan Blue Exclusion Assay, Two Tailed Test